Literature DB >> 16264045

Epidemiological relationships between the common cold and exacerbation frequency in COPD.

J R Hurst1, G C Donaldson, T M A Wilkinson, W R Perera, J A Wedzicha.   

Abstract

Higher exacerbation incidence rates in chronic obstructive pulmonary disease (COPD) are associated with more rapid decline in lung function and poorer quality of life, yet the mechanisms determining susceptibility to exacerbation remain ill-defined. The same viruses responsible for common colds are frequently isolated during exacerbations. The current authors hypothesised that exacerbation frequency may be associated with an increased frequency of colds, and investigated whether increased exacerbation frequency was associated with increased acquisition of colds, or a greater likelihood of exacerbation once a cold has been acquired. A total of 150 patients with COPD completed diary cards recording peak expiratory flow, and respiratory and coryzal symptoms for a median 1,047 days. Annual cold and exacerbation incidence rates (cold and exacerbation frequency) were calculated, and the relationships between these variables were investigated. This analysis is based on 1,005 colds and 1,493 exacerbations. Frequent exacerbators (i.e. those whose exacerbation frequency was greater than the median) experienced significantly more colds than infrequent exacerbators (1.73 versus 0.94.yr(-1)). The likelihood of exacerbation during a cold was unaffected by exacerbation frequency. Patients experiencing frequent colds had a significantly higher exposure to cigarette smoke (46 versus 33 pack-yrs). Exacerbation frequency in chronic obstructive pulmonary disease is associated with an increased frequency of acquiring the common cold, rather than an increased propensity to exacerbation once a cold has been acquired.

Entities:  

Mesh:

Year:  2005        PMID: 16264045     DOI: 10.1183/09031936.05.00043405

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  41 in total

Review 1.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism.

Authors:  J A Wedzicha; J R Hurst
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

3.  Use of "Cold Spell" indices to quantify excess chronic obstructive pulmonary disease (COPD) morbidity during winter (November to March 2000-2007): case study in Porto.

Authors:  Ana Monteiro; Vânia Carvalho; Joaquim Góis; Carlos Sousa
Journal:  Int J Biometeorol       Date:  2012-12-30       Impact factor: 3.787

Review 4.  COPD exacerbations .1: Epidemiology.

Authors:  G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

Review 5.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

6.  Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.

Authors:  Jennifer K Quint; Gavin C Donaldson; James J P Goldring; Ramin Baghai-Ravary; John R Hurst; Jadwiga A Wedzicha
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

7.  Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Xiaodong Wu; Du Chen; Xiaoling Gu; Xin Su; Yong Song; Yi Shi
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

8.  Proton pump inhibitors for chronic obstructive pulmonary disease.

Authors:  Shino Kikuchi; Hissei Imai; Yoko Tani; Tomoko Tajiri; Norio Watanabe
Journal:  Cochrane Database Syst Rev       Date:  2020-08-25

9.  Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT.

Authors:  Jaap C A Trappenburg; Lieselotte Koevoets; Gerdien H de Weert-van Oene; Evelyn M Monninkhof; Jean Bourbeau; Thierry Troosters; Theo J M Verheij; Jan-Willem J Lammers; Augustinus J P Schrijvers
Journal:  BMC Pulm Med       Date:  2009-12-29       Impact factor: 3.317

10.  Warm homes for older people: aims and methods of a randomised community-based trial for people with COPD.

Authors:  Helen Viggers; Philippa Howden-Chapman; Tristram Ingham; Ralph Chapman; Gina Pene; Cheryl Davies; Ann Currie; Nevil Pierse; Helen Wilson; Jane Zhang; Michael Baker; Julian Crane
Journal:  BMC Public Health       Date:  2013-02-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.